Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Thrombocytopenia 2Neuroblastoma 1Lung Neoplasms 1Digestive System Diseases 1Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors 1Chemotherapy-induced Thrombocytopenia 1Chemotherapy Induced Thrombocytopenia 1Cancer Therapy-induced Thrombocytopenia (CTIT) 1

Interventions

eltrombopag 9avatrombopag 6Platelet Transfusion 6romiplostim 4Tranexamic Acid 3Radiotherapy 3Cytarabine 3oprelvekin 2hetrombopag 2Tretinoin 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Cyclophosphamide 2Carboplatin 2Busulfan 2Amplified Fragment Length Polymorphism Analysis 2sodium thiosulfate 1siltuximab 1raltitrexed 1pegfilgrastim 1ofatumumab 1niraparib 1leridistim 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1apixaban 1Vorinostat 1Vitamin B 12 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Thrombocytopenia × hetrombopag × Clear all
NCT05442632 2024-03-13

Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy

Fudan University

Phase 2 Unknown
96 enrolled
Classical hematology

Digestive System Diseases, Thrombocytopenia

NCT06036966 2023-09-14

The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
34 enrolled
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡